X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1752) 1752
Paper (934) 934
Publication (688) 688
Report (250) 250
Data Set (11) 11
Patent (7) 7
Book / eBook (5) 5
Book Chapter (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (1028) 1028
physics (919) 919
particle physics (915) 915
high energy physics - experiment (900) 900
cern lhc coll (848) 848
experimental results (833) 833
physics - high energy physics - experiment (821) 821
high energy physics (699) 699
p p: scattering (584) 584
p p: colliding beams (543) 543
cms (463) 463
phenomenology (459) 459
13000 gev-cms (434) 434
physics of elementary particles and fields (394) 394
scattering [p p] (334) 334
hep (304) 304
colliding beams [p p] (302) 302
nuclear experiment (300) 300
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (290) 290
8000 gev-cms (271) 271
background (229) 229
particle physics - experiment (213) 213
hadron-hadron scattering (208) 208
physical sciences (196) 196
fysik (181) 181
humans (165) 165
index medicus (158) 158
natural sciences (156) 156
naturvetenskap (156) 156
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (147) 147
supersymmetry (132) 132
astrophysics (128) 128
physics, particles & fields (126) 126
transverse momentum: missing-energy (123) 123
mass dependence (120) 120
channel cross section: upper limit (119) 119
male (117) 117
cern lab (115) 115
final state:jet lepton (108) 108
transverse momentum dependence (107) 107
high energy astrophysical phenomena (106) 106
female (101) 101
data analysis method (99) 99
kinematics (96) 96
subatomär fysik (94) 94
subatomic physics (93) 93
jet: bottom (90) 90
rapidity dependence (90) 90
diarrhea (87) 87
bottom: particle identification (86) 86
infant (83) 83
top: pair production (79) 79
elementary particles, quantum field theory (78) 78
channel cross section: branching ratio: upper limit (75) 75
quantum field theories, string theory (75) 75
animals (74) 74
science & technology (74) 74
z0: leptonic decay (72) 72
higgs particle: hadroproduction (70) 70
child, preschool (69) 69
electroweak interaction (69) 69
final state:jet dilepton (69) 69
malnutrition (68) 68
collisions (67) 67
transverse momentum (66) 66
children (64) 64
channel cross section: measured (63) 63
differential cross section: measured (63) 63
muon: pair production (63) 63
astronomy & astrophysics (62) 62
quantum chromodynamics: perturbation theory (62) 62
infectious diseases (61) 61
large hadron collider (60) 60
missing-energy [transverse momentum] (60) 60
atlas (59) 59
mass spectrum: (59) 59
lead (58) 58
sensitivity (58) 58
squark: pair production (58) 58
ciências físicas [ciências naturais] (57) 57
114 physical sciences (56) 56
instrumentation and detectors (56) 56
jet: transverse momentum (56) 56
nuclear and high energy physics (56) 56
bottom: pair production (55) 55
detectors (54) 54
physics and astronomy (54) 54
final state:jet (52) 52
mass: lower limit (52) 52
beyond standard model (51) 51
narrow resonance (51) 51
numerical calculations: monte carlo (51) 51
upper limit [channel cross section] (51) 51
jet lepton (50) 50
engineering (49) 49
nuclear physics (49) 49
structure (49) 49
w: leptonic decay (48) 48
quantum physics (47) 47
analysis (46) 46
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article
by Khachatryan, V and Sirunyan, A.M and Tumasyan, A and Adam, W and Asilar, E and Bergauer, T and Brandstetter, J and Brondolin, E and Dragicevic, M and Erö, J and Flechl, M and Friedl, M and Frühwirth, R and Ghete, V.M and Hartl, C and Hörmann, N and Hrubec, J and Jeitler, M and König, A and Krätschmer, I and Liko, D and Matsushita, T and Mikulec, I and Rabady, D and Rad, N and Rahbaran, B and Rohringer, H and Schieck, J and Strauss, J and Treberer-Treberspurg, W and Waltenberger, W and Wulz, C.-E and Mossolov, V and Shumeiko, N and Suarez Gonzalez, J and Alderweireldt, S and De Wolf, E.A and Janssen, X and Lauwers, J and Van De Klundert, M and Van Haevermaet, H and Van Mechelen, P and Van Remortel, N and Van Spilbeeck, A and Abu Zeid, S and Blekman, F and D'Hondt, J and Daci, N and De Bruyn, I and Deroover, K and Heracleous, N and Lowette, S and Moortgat, S and Moreels, L and Olbrechts, A and Python, Q and Tavernier, S and Van Doninck, W and Van Mulders, P and Van Parijs, I and Brun, H and Caillol, C and Clerbaux, B and De Lentdecker, G and Delannoy, H and Fasanella, G and Favart, L and Goldouzian, R and Grebenyuk, A and Karapostoli, G and Lenzi, T and Léonard, A and Luetic, J and Maerschalk, T and Marinov, A and Randle-conde, A and Seva, T and Vander Velde, C and Vanlaer, P and Yonamine, R and Zenoni, F and Zhang, F and Cimmino, A and Cornelis, T and Dobur, D and Fagot, A and Garcia, G and Gul, M and Poyraz, D and Salva, S and Schöfbeck, R and Sharma, A and Tytgat, M and Van Driessche, W and Yazgan, E and Zaganidis, N and Bakhshiansohi, H and Beluffi, C and Bondu, O and Brochet, S and ... and The CMS Collaboration and CMS Collaboration and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States) and Argonne National Lab. (ANL), Argonne, IL (United States)
Physics Letters B, ISSN 0370-2693, 02/2017, Volume 765, Issue C, pp. 193 - 220
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article